References
- Abraham , G. E. 1974 . Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle . Journal of Clinical Endocrinology and Metabolism , 39 : 340 – 346 .
- Barrett-Connor , E. , Friedlander , N. J. and Khaw , K. T. 1990 . Dehydropiandrosterone sulfate and breast cancer risk . Cancer Research , 50 : 6571 – 6574 .
- Davis , S. R. 1999 . Androgen replacement in women: A commentary . Journal of Clinical Endocrinology and Metabolism , 84 : 1886 – 1891 .
- Laumann , E. O. , Paik , A. and Rosen , R. C. 1999 . Sexual dysfunction in the United States . Prevalence and predictors. Journal of the American Medical Association , 281 : 537 – 544 .
- Mazer , N. 2000 . New clinical applications of transdermal testosterone delivery in men and women . Journal of Controlled Release , 65 : 303 – 315 .
- Rosen, R., Brown, C., Heiman, J., Leiblum, S., Menton, C., Shabsigh, R., Ferguson, D., & D'Agartino, R. Jr. (2000). The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. Journal of Sex & Marital Therapy, 26, 191-208.
- Derogatis, L. R. (2000). Female sexual distress scale (FSDS): Preliminary report. Presented at the 2000 Female Sexual Function Forum, Boston, MA.